All lobbying filings
COHERUS BIOSCIENCES
COHERUS BIOSCIENCES filed a Q2 report for COHERUS BIOSCIENCES, INC. on August 18, 2025.
Lobbying for COHERUS BIOSCIENCES, INC.
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Aug 18, 2025
Expenses
$125,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Lobbyists on this filing
1
-
DAVID SANDERSPreviously held: Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000)
Government bodies contacted
18
Lobbying activity
2
Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act
Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.